Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukaemia

Explore clinical trials studying Chronic Lymphocytic Leukaemia. Study availability and eligibility vary by location and protocol.

12 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukaemia trial results

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Recruiting

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

NCT06651970

Conditions
Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, Heart Diseases, +12 more
Locations
  • Research Site Charlotte, North Carolina, United States
  • Research Site Columbus, Ohio, United States
  • Research Site Philadelphia, Pennsylvania, United States
  • Research Site Brno, Czechia
View all 23 locations
View Trial Details
Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details
Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions
Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations
  • Birmingham Heartlands Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Beatson Hospital Glasgow, United Kingdom
View Trial Details
Completed

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

NCT00457782

Conditions
B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Bronchial Diseases, +31 more
Locations
  • St Bartholomew's Hospital London, United Kingdom
  • UCLH London, United Kingdom
  • Christie Hospital Manchester, United Kingdom
  • Nottingham University NHS Trust Nottingham, United Kingdom
View Trial Details
Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

NCT02933320

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Leicester Royal Infirmary Leicester, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
  • Oxford Cancer and Haematology Centre, Churchill Hospital Oxford, England, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL

NCT01659255

Conditions
Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • CHRU - Hopital Claude HURIEZ Lille, France
  • Centre hospitalier Lyon Sud Lyon, France
  • CHU St Eloi Montpellier, France
  • University Hospital of Wales Cardiff, United Kingdom
View Trial Details
Completed

Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

NCT03582098

Conditions
Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St James Hospital Dublin, Ireland
  • NHS Grampian Aberdeen, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
  • Cheltenham General Hospital Cheltenham, United Kingdom
View all 16 locations
View Trial Details
Completed

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

NCT01805375

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations
  • Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Churchill Hospital Oxford, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details

Related conditions